Table 9.
Biomarkers pg/mL | Low symptom class | Moderate symptom class | Severe symptom class | p value |
---|---|---|---|---|
Mean Ln(IL1-α) levels | ||||
Pre-surgery | 0.95 (1.76) | − 0.25 (1.62) | − 1.92 (1.69) | 0.0012; A>C |
8 weeks post-surgery | 0.20 (1.45) | − 0.46 (1.35) | − 1.90 (1.63) | 0.0079; A>C |
12 months post-surgery | − 1.01 (1.86) | − 0.97 (0.90) | − 1.94 (0.79) | 0.5432 |
Mean Ln(IL-4) levels | ||||
Pre-surgery | − 3.48 (0.92) | − 3.33 (1.01) | − 2.83 (1.31) | 0.0525 |
8 weeks post-surgery | − 3.46 (1.01) | − 3.42(1.08) | − 2.85 (1.21) | 0.0747 |
12 months post-surgery | − 3.31 (1.41) | − 3.63 (0.96) | − 2.99 (1.54) | 0.2226 |
Mean Ln(IL-6) levels | ||||
Pre-surgery | 0.12* (1.32) | 0.28* (1.52) | 1.15 (1.79) | 0.0168; A<C |
4–8 weeks post-surgery | 0.38* (1.34) | 0.66* (1.51) | 1.17 (1.67) | 0.0835 |
12 months post-surgery | 0.30* (1.46) | 0.45* (1.68) | 0.78 (1.94) | 0.4838 |
Mean Ln(IL-8) levels | ||||
Pre-surgery | 2.39 (0.99) | 2.11 (1.08) | 1.63 (1.78) | 0.0334; A>C |
4–8 weeks post-surgery | 2.36(1.15) | 2.04 (1.18) | 1.98 (1.79) | 0.3358 |
12 months post-surgery | 2.45 (1.04) | 2.18 (1.23) | 2.09 (1.19) | 0.3171 |
Mean Ln(IL-10) levels | ||||
Pre-surgery | − 1.38 (0.66) | −1.49 (0.61) | − 1.61 (1.39) | 0.5250 |
4–8 weeks post-surgery | − 1.40 (0.80) | −1.56 (0.84) | − 1.60 (1.39) | 0.5966 |
12 months post-surgery | − 1.25 (0.94) | −1.50 (0.51) | − 1.01 (1.06) | 0.1060 |
Mean Ln(IL-13) levels | ||||
Pre-surgery | − 1.07 (1.19) | −1.05 (1.16) | − 1.75 (1.33) | 0.2814 |
4–8 weeks post-surgery | 1.46 (1.34) | −1.95 (2.11) | − 2.21 (1.88) | 0.4162 |
12 months post-surgery | − 1.04 (1.58) | − 0.67 (1.79) | − 1.41 (1.72) | 0.4407 |
Mean Ln(VEGF) levels | ||||
Pre-surgery | 4.54** (0.62) | 4.75* (0.78) | 4.90*** (0.71) | 0.0681 |
8 weeks post-surgery | 4.50** (0.65) | 4.73* (0.78) | 4.96*** (0.80) | 0.0290; A< C |
12 months post-surgery | 4.27** (0.83) | 4.56* (0.78) | 4.59*** (0.81) | 0.1130 |
Mean Ln(VEGFC) levels | ||||
Pre-surgery | 6.09** (0.44) | 6.03* (0.56) | 6.12 (0.47) | 0.6978 |
4–8 weeks post-surgery | 5.88** (0.50) | 5.89* (0.67) | 6.04 (0.49) | 0.4847 |
12 months post-surgery | 5.93** (0.52) | 5.97* (0.37) | 5.92 (0.53) | 0.8746 |
Mean Ln(VEGFD) levels | ||||
Pre-surgery | 7.34*** (0.62) | 7.26*** (0.54) | 7.30* (0.48) | 0.7835 |
4–8 weeks post-surgery | 6.88*** (0.44) | 6.76*** (0.40) | 6.98* (0.51) | 0.1380 |
12 months post-surgery | 7.03*** (0.63) | 6.95*** (0.54) | 7.18* (0.53) | 0.3228 |
Mean Ln(TNF-α) levels | ||||
Pre-surgery | 0.65*** (0.40) | 0.55*** (0.40) | 0.49 (1.20) | 0.5697 |
4–8 weeks post-surgery | 0.81*** (0.56) | 0.85*** (0.35) | 0.73 (0.96) | 0.7381 |
12 months post-surgery | 0.79*** (0.44) | 0.75*** (0.38) | 0.67 (0.43) | 0.5138 |
A (low), B (moderate), and C (severe) symptom class pairwise differences between the three classes with a Bonferroni correction at the 5% alpha level
p < 0.05
p <0.01
p < 0.001 – repeated measures ANOVA over the three time points show changes over time